Stem Cell Therapy for Alzheimer’s: Phase 1 Trial Data at ISCT 2025
Regeneration Biomedical, Inc. (RBI) announced positive interim results from its Phase 1 clinical trial of a novel Alzheimer’s diseaseAlzheimer’s...
Regeneration Biomedical, Inc. (RBI) announced positive interim results from its Phase 1 clinical trial of a novel Alzheimer’s diseaseAlzheimer’s...
Dianthus Therapeutics has completed enrollment in its Phase 2 MaGic trial of DNTH103 for generalized Myasthenia Gravis (gMG), exceeding...
Inquis Medical announced positive results from its AVENTUS IDE trial, evaluating the safety and efficacy of its AVENTUS Thrombectomy...
ReShape Lifesciences presented pre-clinical data on its Diabetes Neuromodulation device at the 12th Annual Minnesota Neuromodulation Symposium. The device,...
Theratechnologies presented two posters at the 19th Annual American Conference for the Treatment of HIV (ACTHIV 2025), focusing on...
Endogenex, a medical device company, presented positive clinical trial data for its ReCET System, a novel endoscopic procedure for...
Recursion Pharmaceuticals announced preliminary results from its Phase 1b/2 TUPELO trial of REC-4881, a MEK1/2 inhibitor for Familial Adenomatous...
Spherix Global Insights’ recent study of US hematologists reveals growing confidence in gene therapies like Casgevy and Lyfgenia for...
Scilex Holding Company (Nasdaq: SCLX) will present a post-hoc analysis of the C.L.E.A.R. trial at the 27th Annual Meeting...
4D Molecular Therapeutics (4DMT) has received Regenerative Medicine Advanced Therapy (RMAT) designation from the FDA for its product 4D-150,...